Some medicines used for heart problems, like beta-blockers, ACE inhibitors, and calcium channel blockers, have been known to sometimes start new cases of psoriasis or make it worse in some people.

Dental plaque is a complex biofilm at the heart of oral disease. Learn how it causes cavities and gum inflammation and why ...

Explore the latest advancements in rheumatology biosimilars, including FDA approvals, patient switching trends, and ...

Halobetasol (Lexette, Ultravate, Bryhali ) is a corticosteroid drug for treating plaque psoriasis. The brand Lexette is a topical ... One can of Lexette can cost nearly $1,000 without insurance. If a ...

Medicare covers Dovonex — the brand name for the medication calcipotriene — when it’s medically necessary. Read more.

Arcutis Biotherapeutics has received FDA approval for ZORYVE (roflumilast) topical foam 0.3%, which is now available for treating plaque psoriasis on the scalp and body in patients aged 12 and ...

Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one study.

Shared decision-making in plaque psoriasis must address the potential risks and benefits of each treatment option, location and extent of disease, patient preference, and access to care.

According to the latest research by Nova one advisor, the global psoriasis drugs market is valued at USD 21.24 Billion in 2024, and it is expected to reach USD 59.77 Billion by 2034, with a CAGR of 10 ...

Dublin, Nov. 18, 2024 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.The analyst estimates that sales ...

For decades, people with psoriasis have been treated in clinics with narrowband ultraviolet B phototherapy, or light therapy, to reduce sores, scales, and inflammation. Now, new research from the ...